Keyphrases
Acute Gastroenteritis
9%
Africa
18%
African Countries
8%
African Patient
9%
AIDS/HIV
17%
Antiretroviral Therapy
7%
Co-infected Patients
7%
Diarrhea
10%
DS-1-like
9%
Expanded Program on Immunization
7%
Gene Segment
7%
Genome Analysis
29%
Genotype
28%
Genotype 5
11%
Group A Rotavirus
23%
Healthcare Workers
11%
Hepatitis B Surface Antigen (HBsAg)
20%
Hepatitis B Vaccine
19%
Hepatitis B Virus
44%
Hepatitis B Virus DNA
12%
Hepatitis B Virus Infection
13%
Hepatitis C Virus
10%
Hepatitis C Virus Genotypes
11%
Highly Active Antiretroviral Therapy (HAART)
11%
HIV-positive
15%
Hospitalization
9%
Human Immunodeficiency Virus Infection
10%
Lamivudine
7%
Occult Hepatitis B Virus Infection
14%
Porcine
12%
Pre-vaccine
13%
Pretoria
7%
Quantitative PCR
11%
Reassortant
10%
Reassortment
10%
Revaccination
24%
Rotavirus
66%
Rotavirus Diarrhea
11%
Rotavirus Genotypes
12%
Rotavirus Strains
60%
Rotavirus Surveillance
7%
Rotavirus Vaccine
34%
South Africa
69%
South African
67%
South African children
15%
Sub-Saharan Africa
10%
Vaccine Introduction
37%
Virus
9%
Whole Genome
12%
Zambia
10%
Immunology and Microbiology
Cladistics
9%
Coinfection
10%
DNA Virus
6%
Drug Resistance
7%
Epitope
7%
Evolution
9%
Gastroenteritis
16%
Genetic Variability
8%
HBsAg
19%
Hepatitis B
24%
Hepatitis B Antigen
19%
Hepatitis B Core Antibody
5%
Hepatitis B Surface Antibody
5%
Hepatitis B Virus
55%
Hepatitis B(e) Antigen
5%
Hepatitis C Virus
13%
Hepatitis G Virus
5%
Human Immunodeficiency Virus
52%
Human Immunodeficiency Virus Type 1 Subtype C
7%
Human Rotavirus
16%
Immunology
7%
Lineages
12%
NS5B
5%
Phylogeny
8%
Pig
12%
Prevalence
27%
Real-Time Polymerase Chain Reaction
5%
Reassortment
20%
Rotavirus
100%
Rotavirus Vaccine
32%
Serotype
5%
Vertebral Column
5%
Whole Genome Sequencing
6%